doi: 10.1001/jama.2021.14996.
COVID-19 Vaccine Nasal Spray
- PMID: 34581751
- DOI: 10.1001/jama.2021.14996
Item in Clipboard
COVID-19 Vaccine Nasal Spray
JAMA.
.
No abstract available
Similar articles
-
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.Scand J Immunol. 2006 Mar;63(3):223-31. doi: 10.1111/j.1365-3083.2006.01730.x. Scand J Immunol. 2006. PMID: 16499576
-
Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model.J Pharm Sci. 2021 Jun;110(6):2501-2507. doi: 10.1016/j.xphs.2021.01.017. Epub 2021 Jan 23. J Pharm Sci. 2021. PMID: 33493479 Free PMC article.
-
Potential Role of Xylitol Plus Grapefruit Seed Extract Nasal Spray Solution in COVID-19: Case Series.Cureus. 2020 Nov 3;12(11):e11315. doi: 10.7759/cureus.11315. Cureus. 2020. PMID: 33173650 Free PMC article.
-
Developments in the formulation and delivery of spray dried vaccines.Hum Vaccin Immunother. 2017 Oct 3;13(10):2364-2378. doi: 10.1080/21645515.2017.1356952. Hum Vaccin Immunother. 2017. PMID: 28925794 Free PMC article. Review.
-
Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis.Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3477-3486. doi: 10.1007/s00405-015-3832-1. Epub 2015 Nov 6. Eur Arch Otorhinolaryngol. 2016. PMID: 26545381 Review.
Cited by
-
Construction and application of adenoviral vectors.Mol Ther Nucleic Acids. 2023 Sep 9;34:102027. doi: 10.1016/j.omtn.2023.09.004. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37808925 Free PMC article. Review.
-
Acceptability for the influenza virus vector COVID-19 vaccine for intranasal spray: A cross-sectional survey in Beijing, China.Hum Vaccin Immunother. 2023 Aug 1;19(2):2235963. doi: 10.1080/21645515.2023.2235963. Hum Vaccin Immunother. 2023. PMID: 37450312 Free PMC article.
-
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status.Vaccines (Basel). 2023 Feb 13;11(2):432. doi: 10.3390/vaccines11020432. Vaccines (Basel). 2023. PMID: 36851309 Free PMC article. Review.
-
A Supine Position and Dual-Dose Applications Enhance Spray Dosing to the Posterior Nose: Paving the Way for Mucosal Immunization.Pharmaceutics. 2023 Jan 20;15(2):359. doi: 10.3390/pharmaceutics15020359. Pharmaceutics. 2023. PMID: 36839681 Free PMC article.
-
Development of Nasal Vaccines and the Associated Challenges.Pharmaceutics. 2022 Sep 20;14(10):1983. doi: 10.3390/pharmaceutics14101983. Pharmaceutics. 2022. PMID: 36297419 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
